Telepsychiatry provider Talkiatry announced the close of its Series D financing round, securing $210 million in funding led by Perceptive Advisors. The round brings the startup’s overall fundraising total to more than $400 million. Other investors participating in the round include Andreessen Horowitz, blisce/, Sofina, and Left Lane Capital.
Founded in 2019, Talkiatry aims to address the provider shortage and care access crisis in mental health by expanding access to virtual psychiatry and therapy nationally. The company employs more than 800 psychiatrists and 300 therapists and has delivered 3 million patient visits to date. It is in-network with more than 100 payers nationwide.
Platform and Patient Outcomes
Patients using Talkiatry’s platform begin with a brief intake survey and are then matched with a clinician based on their needs and availability, with virtual visits following. CEO Robert Krayn emphasized efforts to reduce friction for patients, including features like “insurance discovery” so they don’t have to hunt for an insurance card. The company is also investing in new engagement models between visits to capture context that can improve care.
User data demonstrates that the model can boost patient outcomes, with 87% of anxiety patients and 86% of depression patients reporting symptom improvement after just two visits. After two visits, 67% of anxiety patients and 62% of depression patients report no longer having clinically significant symptoms. Patients often access the platform after being referred by their traditional provider, with Talkiatry having partnered with more than 50 health systems to take referrals.
Business Model and Competitive Position
The company makes its money via a mix of traditional reimbursement and value-based arrangements tied to performance and outcomes, with no subscription-based payment models or pharmacy affiliations. Despite the size of the Series D round, CEO Krayn declared that Talkiatry has no imminent plans for an IPO and is instead focused on “doing the work needed to responsibly run a large scale enterprise.”
Krayn maintains that Talkiatry is the only provider with a focus specifically on psychiatry and claims to be the largest private employer of psychiatrists in the U.S. The company stands out as a full-stack provider group that builds its own technology and employs its own clinicians. Talkiatry reports therapeutic alliance ratings 22% higher than industry peers, with 92% of patients building a strong rapport with their clinicians.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://medcitynews.com/2026/02/talkiatry-psychiatry-healthcare-startup/